Twice-daily intravenous bolus tacrolimus infusion: A safe and effective regimen for graft-versus-host disease prophylaxis

Hamza Hashmi,Shruti Bhandari,Rohit Kumar,Prashant Tripathi, Jill Blancett Rhodes,Lindsay Figg,Timothy Baize,Maxwell M Krem,Mohamed Hegazi,Robert Emmons

Hematology/Oncology and Stem Cell Therapy（2020）

引用 1|浏览2

暂无评分

摘要

We conclude that administration of IV tacrolimus twice daily over 4 h may be safe and effective in preventing GvHD in allogeneic hematopoietic cell transplant.

查看译文

关键词

Allogeneic hematopoietic cell transplant,Tacrolimus,Graft-versus-host disease

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要